← Back to All Filings

UNH CFO Acquires Dividend Equivalents on Existing RSUs

Low SignificanceDecember 18, 2025 at 5:36:46 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH CFO Acquires Dividend Equivalents on Existing RSUs

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: DeVeydt Wayne S Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 70.042 • Price: $0.00 • Value: $0 • Owned After: 10,661.941

Key Insight: This is a routine, non-cash acquisition of dividend equivalents on previously granted Restricted Stock Units (RSUs), not a market purchase.

Market Context: The transaction has no cash value and represents a negligible fraction of the company's shares outstanding, indicating no new insider sentiment.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer acquired a small number of shares as dividend equivalents on existing Restricted Stock Units (RSUs), a routine, non-cash event with no market impact.
  • Market Impact: Neutral. This transaction is an automatic reinvestment related to prior compensation and does not signal a new investment decision by the insider.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHospital & Medical Service Plans

Insider Information

FieldValue
NameDeVeydt Wayne S
CIK0001321392
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA
Security TypeCommon Stock
Shares Involved70.042
Price Per Share$0.00
Total Value$0
Shares Owned After10,661.941
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted70.042
% of Shares Outstanding<0.00001%
Post-Transaction Ownership10,661.941 shares (<0.0012% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $291.55 billion, this $0 value transaction is immaterial.
  • Ownership Concentration: The insider's total holdings remain a very small fraction of the total shares outstanding.
  • Dilution Impact: The issuance of 70 shares has a negligible dilutive effect on the 905.67 million shares outstanding.
  • Transaction Significance: The transaction is a standard part of an executive compensation plan and carries no significant trading signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a non-discretionary, non-cash acquisition related to dividend payments on existing equity awards. It does not reflect a change in the insider's sentiment or a new investment decision.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open market transaction.
  • Sentiment Indicator: Neutral. The filing is procedural and related to executive compensation.

Additional Context

Transaction Notes

  • Special Circumstances: As noted in the filing's footnote, the shares represent dividend equivalents paid on outstanding restricted stock units. These are subject to the same vesting conditions as the underlying RSUs.
Topics:#SECFiling#Form4#UNH#UnitedHealth#InsiderTrading#StockMarket#Finance#RSU

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.